ReviewCurrent rheumatology reports2025
What can Animal Models tell us About T Cells in Spondyloarthritis Pathogenesis?
Review in Current rheumatology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewSpondyloarthritis animal models such as the HLA-B27 transgenic rat, SKG mouse and cytokine overexpression models have proven useful for testing hypotheses regarding pathogenesis. Recent developments in the field from human studies have shifted attention to HLA-B2705 restricted CD8+ T cell clonotype expansion and the "arthritogenic peptide" theory. Since human and rodent MHC and T cell compartments differ, translatability comes into question. In this review, we will discuss the advantages and caveats of several spondyloarthritis rodent models. We will review classic studies and more recent reports providing insight into pathologic T cells outside the canonical paradigm of MHC Class I-CD8+ T cell interaction. RECENT
findingsAnimal models have revealed requisite "ingredients' for a spondyloarthritis phenotype, including inflammatory mediators and lymphoid cell types. Most of these models highlight the role of Th17 cells and other IL-17 producing cells. Indeed, the IL-23 minicircle model directly led to the identification of IL-17 producing γδ T cells in typical spondyloarthritis anatomic locations. In addition to identifying lymphocyte players, animal models have elucidated T cell regulation, including innate immune (e.g. neutrophil) T cell crosstalk and gut-joint trafficking. Current studies are also beginning to clarify roles for innate lymphocytic cells such as MAIT and iNKT cells. Animal model studies have provided vital insight into T cell pathogenic mechanisms outside canonical MHC Class I-CD8 interaction. Many of these findings have been replicated in human subjects. Furthermore, work from animal models directly supported the development of IL17 and IL23 targeting therapeutics, attesting to their relevance. MAIN TEXT: (~ 4246 words), 1 Figure and 1 Table.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.